{"id":"https://openalex.org/W1985335252","doi":"https://doi.org/10.1002/cam4.71","title":"Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab","display_name":"Correlation of angiogenic biomarker signatures with clinical outcomes in metastatic colorectal cancer patients receiving capecitabine, oxaliplatin, and bevacizumab","publication_year":2013,"publication_date":"2013-03-06","ids":{"openalex":"https://openalex.org/W1985335252","doi":"https://doi.org/10.1002/cam4.71","mag":"1985335252","pmid":"https://pubmed.ncbi.nlm.nih.gov/23634291","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3639662"},"language":"en","primary_location":{"id":"doi:10.1002/cam4.71","doi":"https://doi.org/10.1002/cam4.71","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cam4.71","pdf_url":null,"source":{"id":"https://openalex.org/S2754843627","display_name":"Cancer Medicine","issn_l":"2045-7634","issn":["2045-7634"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Medicine","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1002/cam4.71","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037380551","display_name":"Yingmiao Liu","orcid":"https://orcid.org/0000-0003-3516-5844","observed_orcids":["https://orcid.org/0000-0003-3516-5844"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yingmiao Liu","raw_affiliation_strings":["Department of Medicine, Duke University Medical Center, Durham, North Carolina,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Duke University Medical Center, Durham, North Carolina,","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062010101","display_name":"Mark D. Starr","orcid":"https://orcid.org/0009-0003-9664-6235","observed_orcids":["https://orcid.org/0009-0003-9664-6235"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark D. Starr","raw_affiliation_strings":["Department of Medicine, Duke University Medical Center, Durham, North Carolina,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Duke University Medical Center, Durham, North Carolina,","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043601003","display_name":"Anuradha Bulusu","orcid":"https://orcid.org/0000-0002-0302-5751","observed_orcids":["https://orcid.org/0000-0002-0302-5751"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anuradha Bulusu","raw_affiliation_strings":["Department of Biostatistics and Bioinformatics Duke University Medical Center Durham North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics and Bioinformatics Duke University Medical Center Durham North Carolina","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084337375","display_name":"Herbert Pang","orcid":"https://orcid.org/0000-0002-7896-6716","observed_orcids":["https://orcid.org/0000-0002-7896-6716"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Herbert Pang","raw_affiliation_strings":["Department of Biostatistics and Bioinformatics Duke University Medical Center Durham North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics and Bioinformatics Duke University Medical Center Durham North Carolina","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110551700","display_name":"Nan Soon Wong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800542734","display_name":"Mount Elizabeth Hospital","ror":"https://ror.org/019z9dk17","country_code":"SG","type":"healthcare","lineage":["https://openalex.org/I2800542734"]}],"countries":["SG"],"is_corresponding":false,"raw_author_name":"Nan Soon Wong","raw_affiliation_strings":["OncoCare Cancer Centre Mount Elizabeth Medical Centre Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OncoCare Cancer Centre Mount Elizabeth Medical Centre Singapore","institution_ids":["https://openalex.org/I2800542734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069465431","display_name":"Wanda Honeycutt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wanda Honeycutt","raw_affiliation_strings":["Department of Medicine, Duke University Medical Center, Durham, North Carolina,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Duke University Medical Center, Durham, North Carolina,","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003099045","display_name":"Anthony Amara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony Amara","raw_affiliation_strings":["Department of Medicine, Duke University Medical Center, Durham, North Carolina,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Duke University Medical Center, Durham, North Carolina,","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046311492","display_name":"Herbert I. Hurwitz","orcid":"https://orcid.org/0000-0003-3242-9197","observed_orcids":["https://orcid.org/0000-0003-3242-9197"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Herbert I. Hurwitz","raw_affiliation_strings":["Department of Medicine, Duke University Medical Center, Durham, North Carolina,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Duke University Medical Center, Durham, North Carolina,","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044586794","display_name":"Andrew B. Nixon","orcid":"https://orcid.org/0000-0003-3971-2964","observed_orcids":["https://orcid.org/0000-0003-3971-2964"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Andrew B. Nixon","raw_affiliation_strings":["Department of Medicine, Duke University Medical Center, Durham, North Carolina,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Duke University Medical Center, Durham, North Carolina,","institution_ids":["https://openalex.org/I4210126298"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5044586794"],"corresponding_institution_ids":["https://openalex.org/I4210126298"],"apc_list":{"value":4700,"currency":"USD","value_usd":4700},"apc_paid":{"value":4700,"currency":"USD","value_usd":4700},"fwci":4.6399,"has_fulltext":false,"cited_by_count":74,"citation_normalized_percentile":{"value":0.95379552,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"2","issue":"2","first_page":"234","last_page":"242"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.006800000090152025,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.9869999885559082},{"id":"https://openalex.org/keywords/capecitabine","display_name":"capecitabine","score":0.878000020980835},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":1.0},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":1.0},{"id":"https://openalex.org/keywords/angiogenic-biomarkers","display_name":"angiogenic biomarkers","score":0.8840000033378601},{"id":"https://openalex.org/keywords/plasma-biomarkers","display_name":"plasma biomarkers","score":0.7889999747276306},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8190000057220459},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":1.0},{"id":"https://openalex.org/keywords/angiopoietin-2","display_name":"angiopoietin-2","score":0.8460000157356262},{"id":"https://openalex.org/keywords/von-willebrand-factor","display_name":"von Willebrand factor","score":0.8519999980926514},{"id":"https://openalex.org/keywords/vcam-1","display_name":"VCAM-1","score":0.9210000038146973},{"id":"https://openalex.org/keywords/transforming-growth-factor-beta","display_name":"TGF-beta","score":0.5860000252723694},{"id":"https://openalex.org/keywords/insulin-like-growth-factor-i","display_name":"insulin-like growth factor I","score":0.8560000061988831},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.7820000052452087},{"id":"https://openalex.org/keywords/risk-stratification","display_name":"risk stratification","score":0.6259999871253967}],"concepts":[{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.8966549038887024},{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.8826236724853516},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.8230795860290527},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.819568932056427},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.8048413991928101},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6297485828399658},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.5850717425346375},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5832138061523438},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.4994316101074219},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.44730138778686523},{"id":"https://openalex.org/C144301174","wikidata":"https://www.wikidata.org/wiki/Q7893852","display_name":"Univariate analysis","level":3,"score":0.43564289808273315},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.3912748694419861},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3002546727657318},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.26355236768722534},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.20145168900489807},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069287","descriptor_name":"Capecitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077150","descriptor_name":"Oxaliplatin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009944","descriptor_name":"Organoplatinum Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009944","descriptor_name":"Organoplatinum Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1002/cam4.71","doi":"https://doi.org/10.1002/cam4.71","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cam4.71","pdf_url":null,"source":{"id":"https://openalex.org/S2754843627","display_name":"Cancer Medicine","issn_l":"2045-7634","issn":["2045-7634"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Medicine","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2639861","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3639662","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3639662","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3639662","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Med","raw_type":"Text"},{"id":"pmid:23634291","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23634291","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer medicine","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:doaj.org/article:113c8a5be0e74db0bbb374f15eb404c9","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/113c8a5be0e74db0bbb374f15eb404c9","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cancer Medicine, Vol 2, Iss 2, Pp 234-242 (2013)","raw_type":"article"},{"id":"pmh:oai:hub.hku.hk:10722/194850","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10722/194850","pdf_url":null,"source":{"id":"https://openalex.org/S4377196271","display_name":"The HKU Scholars Hub (University of Hong Kong)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I889458895","host_organization_name":"University of Hong Kong","host_organization_lineage":["https://openalex.org/I889458895"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1002/cam4.71","doi":"https://doi.org/10.1002/cam4.71","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cam4.71","pdf_url":null,"source":{"id":"https://openalex.org/S2754843627","display_name":"Cancer Medicine","issn_l":"2045-7634","issn":["2045-7634"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1428888813","display_name":"Wound Angiogenesis as a Biomarker for Tumor Angiogenesis","funder_award_id":"K24CA113755","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4444900377","display_name":null,"funder_award_id":"K24-CA113755-01A1","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1554944419","https://openalex.org/W1606278307","https://openalex.org/W1967621966","https://openalex.org/W1968014316","https://openalex.org/W1975266720","https://openalex.org/W1995044555","https://openalex.org/W2015331990","https://openalex.org/W2017322644","https://openalex.org/W2022066554","https://openalex.org/W2023921074","https://openalex.org/W2056408500","https://openalex.org/W2081596239","https://openalex.org/W2089178479","https://openalex.org/W2095201384","https://openalex.org/W2101112965","https://openalex.org/W2101995865","https://openalex.org/W2102055984","https://openalex.org/W2117454747","https://openalex.org/W2125447919","https://openalex.org/W2137974862","https://openalex.org/W2143743735","https://openalex.org/W2145372211","https://openalex.org/W2146412564","https://openalex.org/W2157769714","https://openalex.org/W2166889065","https://openalex.org/W2560403716","https://openalex.org/W2589417649","https://openalex.org/W2787894218","https://openalex.org/W4205337121"],"related_works":["https://openalex.org/W7099752148","https://openalex.org/W2186364980","https://openalex.org/W4200493332","https://openalex.org/W1968014316","https://openalex.org/W2257057889","https://openalex.org/W2113058482","https://openalex.org/W2755858865","https://openalex.org/W2077980958","https://openalex.org/W2227420607","https://openalex.org/W7164409293"],"abstract_inverted_index":{"A":[0,166],"novel":[1],"combination":[2],"of":[3,39,56,113,123,140,148,158,169,181,199,228],"capecitabine,":[4,30],"oxaliplatin,":[5,31],"and":[6,32,52,71,80,106,115,129,161,173,178,205,214,237],"bevacizumab":[7,33],"was":[8,151,207],"evaluated":[9,63,102],"in":[10,15,47,231,249],"colorectal":[11],"cancer":[12],"patients":[13,28,49,182,211],"enrolled":[14],"a":[16,176,196],"phase":[17],"II":[18],"clinical":[19,40,242,252],"trial.":[20],"In":[21],"this":[22,232],"retrospective":[23],"analysis,":[24],"plasma":[25,230],"samples":[26],"from":[27,143],"receiving":[29],"were":[34,45,62,74,89,101],"analyzed":[35],"to":[36,98,145,209],"investigate":[37],"biomarkers":[38,44,239],"benefit.":[41],"Forty-one":[42],"protein":[43],"tested":[46],"38":[48],"at":[50,69],"baseline":[51,70,144,167],"after":[53],"two":[54],"cycles":[55],"drug":[57],"administration.":[58],"Correlations":[59],"among":[60],"analytes":[61],"by":[64,84,103,108],"Spearman":[65],"analysis.":[66,86],"Analyte":[67],"levels":[68,112,122,142],"changes":[72,157],"on-treatment":[73],"correlated":[75,118,131,152,163],"with":[76,119,132,153,164,241],"progression-free":[77],"survival":[78,82],"(PFS)":[79],"overall":[81],"(OS)":[83],"univariate":[85],"Multivariate":[87],"analyses":[88,100],"determined":[90],"using":[91],"the":[92,146],"Cox":[93],"proportional":[94],"hazard":[95],"model.":[96],"Time":[97],"event":[99],"Kaplan-Meier":[104],"analysis":[105,227],"compared":[107],"log-rank":[109],"test.":[110],"Baseline":[111],"vWF":[114],"Ang-2":[116,130],"significantly":[117],"PFS,":[120,154],"while":[121,155],"VCAM-1,":[124],"vWF,":[125],"TSP-2,":[126,160],"IL-8,":[127],"MMP-2,":[128],"OS":[133],"(P":[134],"<":[135],"0.05).":[136],"The":[137],"fold":[138,156],"change":[139],"IGF-1":[141],"end":[147],"cycle":[149],"2":[150],"Ang-2,":[159,170,200],"TGF-\u03b22":[162],"OS.":[165],"signature":[168,197],"IGFBP-3,":[171],"IL-6,":[172,202],"VCAM-1":[174],"identified":[175,234],"low-risk":[177,215],"high-risk":[179],"group":[180],"(OS:":[183],"33.9":[184],"months":[185,219],"vs.":[186,220],"18.1":[187],"months,":[188,222],"respectively,":[189],"P":[190,223],"=":[191,224],"0.016).":[192],"For":[193],"treatment-related":[194,238],"changes,":[195],"consisting":[198],"E-Cadherin,":[201],"MCP-1,":[203],"OPN,":[204],"TGF-\u03b21":[206],"able":[208],"stratify":[210],"into":[212],"high-":[213],"groups":[216],"(PFS:":[217],"7.7":[218],"15.5":[221],"0.004).":[225],"Multiplex":[226],"patient":[229],"trial":[233],"several":[235],"baseline-":[236],"associated":[240],"outcome.":[243],"These":[244],"findings":[245],"merit":[246],"further":[247],"exploration":[248],"larger,":[250],"controlled":[251],"trials.":[253]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}